Newsfeeds Archive - Page 2 of 3

1 minute read

Dividends

Carpenter Tech: Dividend Insights

By Benzinga Insights

October 18, 10:45 AM

Friday marks the last chance for investors to receive the next dividend payout from Carpenter Tech (NYSE:CRS). What’s…

CRS

2 minute read

Jim Cramer Writes Off Entire Telco, Wireless Industry: ‘It’s Such A Shame’

By Priya Nigam

September 22, 8:23 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Carpenter Technology Corporation (NYSE: CRS) is a "very, very good company, Philadelphia-area company.

AEHR

2 minute read

CRS’s Future Looks Bright: Analyst Forecasts Steady Earnings Growth And Margin Improvements For FY27

By Nabaparna Bhattacharya

September 13, 3:23 PM

Benchmark analyst Josh Sullivan reiterated a Buy rating on Carpenter Technology Corporation (NYSE: CRS),

1 minute read

Analyst Ratings

The Latest Analyst Ratings for Carpenter Tech

By Benzinga Insights

September 13, 1:00 PM

Carpenter Tech (NYSE:CRS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CRS

1 minute read

Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

September 13, 10:13 AM

U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

AMPX

2 minute read

GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday

By Lisa Levin

September 13, 8:45 AM

Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in pre-market trading.

CASY